The aims of this work were (1) to test whether ApN affords similar anti-inflammatory properties in human dystrophic myotubes, (2) to identify novel myokines targeted by ApN in these DMD myotubes, and (3) to unravel the more proximal events underlying the anti-inflammatory effects of ApN. Here, ANPEP is linked to Duchenne muscular dystrophy.